CRVS - Corvus Pharmaceuticals EPS beats by $1.16 March, 25 2021 08:59 AM Corvus Pharmaceuticals Inc. Corvus Pharmaceuticals (CRVS): Q4 GAAP EPS of $0.92 beats by $1.16.Cash, cash equivalents and marketable securities of $44.3MPress Release For further details see: Corvus Pharmaceuticals EPS beats by $1.16